Literature DB >> 26818025

Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer.

B G Muller1, A Swaan1,2, D M de Bruin1,2, W van den Bos1, A W Schreurs3, D J Faber2, E C H Zwartkruis4, L Rozendaal4, A N Vis5, J A Nieuwenhuijzen5, R J A van Moorselaar5, T G van Leeuwen2, J J M C H de la Rosette1.   

Abstract

OBJECTIVE: To design and demonstrate a customized tool to generate histologic sections of the prostate that directly correlate with needle-based optical coherence tomography pullback measurements.
MATERIALS AND METHODS: A customized tool was created to hold the prostatectomy specimens during optical coherence tomography measurements and formalin fixation. Using the tool, the prostate could be sliced into slices of 4 mm thickness through the optical coherence tomography measurement trajectory. In this way, whole-mount pathology slides were produced in exactly the same location as the optical coherence tomography measurements were performed. Full 3-dimensional optical coherence tomography pullbacks were fused with the histopathology slides using the 3-dimensional imaging software AMIRA, and images were compared.
RESULTS: A radical prostatectomy was performed in a patient (age: 68 years, prostate-specific antigen: 6.0 ng/mL) with Gleason score 3 + 4 = 7 in 2/5 biopsy cores on the left side (15%) and Gleason score 3 + 4 = 7 in 1/5 biopsy cores on the right side (5%). Histopathology after radical prostatectomy showed an anterior located pT2cNx adenocarcinoma (Gleason score 3 + 4 = 7). Histopathological prostate slides were produced using the customized tool for optical coherence tomography measurements, fixation, and slicing of the prostate specimens. These slides correlated exactly with the optical coherence tomography images. Various structures, for example, Gleason 3 + 4 prostate cancer, stroma, healthy glands, and cystic atrophy with septae, could be identified both on optical coherence tomography and on the histopathological prostate slides.
CONCLUSION: We successfully designed and applied a customized tool to process radical prostatectomy specimens to improve the coregistration of whole mount histology sections to fresh tissue optical coherence tomography pullback measurements. This technique will be crucial in validating the results of optical coherence tomography imaging studies with histology and can easily be applied in other solid tissues as well, for example, lung, kidney, breast, and liver. This will help improve the efficacy of optical coherence tomography in cancer detection and staging in solid organs.

Entities:  

Keywords:  histopathology; needle-based; optical coherence tomography; prostate; validation

Mesh:

Substances:

Year:  2016        PMID: 26818025      PMCID: PMC5616116          DOI: 10.1177/1533034615626614

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  31 in total

1.  Localized measurement of optical attenuation coefficients of atherosclerotic plaque constituents by quantitative optical coherence tomography.

Authors:  Freek J van der Meer; Dirk J Faber; David M Baraznji Sassoon; Maurice C Aalders; Gerard Pasterkamp; Ton G van Leeuwen
Journal:  IEEE Trans Med Imaging       Date:  2005-10       Impact factor: 10.048

Review 2.  Optical coherence tomography imaging of the pancreas: a needle-based approach.

Authors:  Joo Ha Hwang; Michael J Cobb; Michael B Kimmey; Xingde Li
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

3.  Measuring the optical characteristics of medulloblastoma with optical coherence tomography.

Authors:  Barry Vuong; Patryk Skowron; Tim-Rasmus Kiehl; Matthew Kyan; Livia Garzia; Cuiru Sun; Michael D Taylor; Victor X D Yang
Journal:  Biomed Opt Express       Date:  2015-03-25       Impact factor: 3.732

4.  A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.

Authors:  Vijay Shah; Thomas Pohida; Baris Turkbey; Haresh Mani; Maria Merino; Peter A Pinto; Peter Choyke; Marcelino Bernardo
Journal:  Rev Sci Instrum       Date:  2009-10       Impact factor: 1.523

5.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

6.  Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.

Authors:  Hari Trivedi; Baris Turkbey; Ardeshir R Rastinehad; Compton J Benjamin; Marcelino Bernardo; Thomas Pohida; Vijay Shah; Maria J Merino; Bradford J Wood; W Marston Linehan; Aradhana M Venkatesan; Peter L Choyke; Peter A Pinto
Journal:  Urology       Date:  2012-01       Impact factor: 2.649

7.  Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.

Authors:  Konstantinos Stamatiou; Alevizos Alevizos; Vasilisa Karanasiou; Anargiros Mariolis; Constantinos Mihas; Marek Papathanasiou; Konstantinos Bovis; Frangiskos Sofras
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

Review 8.  Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?

Authors:  Hashim Uddin Ahmed; Mark Emberton
Journal:  World J Urol       Date:  2008-08-14       Impact factor: 4.226

9.  Modified full-field optical coherence tomography: A novel tool for rapid histology of tissues.

Authors:  Manu Jain; Nidhi Shukla; Maryem Manzoor; Sylvie Nadolny; Sushmita Mukherjee
Journal:  J Pathol Inform       Date:  2011-06-14

10.  Real-time three-dimensional optical coherence tomography image-guided core-needle biopsy system.

Authors:  Wei-Cheng Kuo; Jongsik Kim; Nathan D Shemonski; Eric J Chaney; Darold R Spillman; Stephen A Boppart
Journal:  Biomed Opt Express       Date:  2012-04-30       Impact factor: 3.732

View more
  3 in total

1.  Confocal Laser Endomicroscopy and Optical Coherence Tomography for the Diagnosis of Prostate Cancer: A Needle-Based, In Vivo Feasibility Study Protocol (IDEAL Phase 2A).

Authors:  Abel Swaan; Christophe K Mannaerts; Matthijs Jv Scheltema; Jakko A Nieuwenhuijzen; C Dilara Savci-Heijink; Jean Jmch de la Rosette; R Jeroen A van Moorselaar; Ton G van Leeuwen; Theo M de Reijke; Daniel Martijn de Bruin
Journal:  JMIR Res Protoc       Date:  2018-05-21

2.  The clinical usefulness of optical coherence tomography during cancer interventions.

Authors:  Labrinus van Manen; Jouke Dijkstra; Claude Boccara; Emilie Benoit; Alexander L Vahrmeijer; Michalina J Gora; J Sven D Mieog
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-20       Impact factor: 4.553

3.  Current trends for customized biomedical software tools.

Authors:  Haseeb Ahmad Khan
Journal:  Bioinformation       Date:  2017-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.